Takaisin Tulosta

Kaksisuuntainen mielialahäiriö, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
11.2.2021

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Kaksisuuntainen mielialahäiriö «»1näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Allen MH, Hirschfeld RM, Wozniak PJ ym. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am J Psychiatry 2006;163:272-5 «PMID: 16449481»PubMed
  2. Altshuler LL, Sugar CA, McElroy SL ym. Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison. Am J Psychiatry 2017;174:266-276 «PMID: 28135846»PubMed
  3. Amerio A, Ossola P, Scagnelli F ym. Safety and efficacy of lithium in children and adolescents: A systematic review in bipolar illness. Eur Psychiatry 2018;54:85-97 «PMID: 30130637»PubMed
  4. Amsterdam JD, Lorenzo-Luaces L, Soeller I ym. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study. J Affect Disord 2015;185:31-7 «PMID: 26143402»PubMed
  5. Amsterdam JD, Lorenzo-Luaces L, Soeller I ym. Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate. Br J Psychiatry 2016;208:359-65 «PMID: 26892848»PubMed
  6. Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am J Psychiatry 2010;167:792-800 «PMID: 20360317»PubMed
  7. Amsterdam JD, Shults J. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study. Int Clin Psychopharmacol 2005;20:257-64 «PMID: 16096516»PubMed
  8. Anaya C, Martinez Aran A, Ayuso-Mateos JL ym. A systematic review of cognitive remediation for schizo-affective and affective disorders. J Affect Disord 2012;142:13-21 «PMID: 22840620»PubMed
  9. Bahji A, Hawken ER, Sepehry AA ym. ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatr Scand 2019;139:214-226 «PMID: 30506992»PubMed
  10. BALANCE investigators and collaborators., Geddes JR, Goodwin GM ym. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010;375:385-95 «PMID: 20092882»PubMed
  11. Baldessarini RJ, Tondo L, Floris G ym. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J Affect Disord 2000;61:13-22 «PMID: 11099736»PubMed
  12. Ball JR, Mitchell PB, Corry JC ym. A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. J Clin Psychiatry 2006;67:277-86 «PMID: 16566624»PubMed
  13. Barnes CW, Hadzi-Pavlovic D, Wilhelm K ym. A web-based preventive intervention program for bipolar disorder: outcome of a 12-months randomized controlled trial. J Affect Disord 2015;174:485-92 «PMID: 25554993»PubMed
  14. Baryshnikov I, Aaltonen K, Koivisto M ym. Differences and overlap in self-reported symptoms of bipolar disorder and borderline personality disorder. Eur Psychiatry 2015;30:914-9 «PMID: 26647866»PubMed
  15. Baryshnikov I, Suvisaari J, Aaltonen K ym. Self-reported psychosis-like experiences in patients with mood disorders. Eur Psychiatry 2018;51:90-97 «PMID: 28797561»PubMed
  16. Bellani M, Biagianti B, Zovetti N ym. The effects of cognitive remediation on cognitive abilities and real-world functioning among people with bipolar disorder: A systematic review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders. J Affect Disord 2019;257:691-697 «PMID: 31377606»PubMed
  17. Berk M, Daglas R, Dandash O ym. Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trial. Br J Psychiatry 2017;210:413-421 «PMID: 28254958»PubMed
  18. Bond K, Anderson IM. Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials. Bipolar Disord 2015;17:349-62 «PMID: 25594775»PubMed
  19. Bonnin CDM, Valls E, Rosa AR ym. Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levels. Eur Neuropsychopharmacol 2019;29:701-710 «PMID: 31076186»PubMed
  20. Bonnin CM, Reinares M, Martínez-Arán A ym. Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory. Psychol Med 2016;46:291-301 «PMID: 26387583»PubMed
  21. Bonnin CM, Torrent C, Arango C ym. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome. Br J Psychiatry 2016;208:87-93 «PMID: 26541692»PubMed
  22. Bowden CL, Brugger AM, Swann AC ym. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994;271:918-24 «PMID: 8120960»PubMed
  23. Bowden CL, Calabrese JR, Sachs G ym. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400 «PMID: 12695317»PubMed
  24. Bowden CL, Grunze H, Mullen J ym. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005;66:111-21 «PMID: 15669897»PubMed
  25. Bowden CL, Singh V, Weisler R ym. Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression. Acta Psychiatr Scand 2012;126:342-50 «PMID: 22708645»PubMed
  26. Bowden CL, Swann AC, Calabrese JR ym. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 2006;67:1501-10 «PMID: 17107240»PubMed
  27. Bowden CL, Vieta E, Ice KS ym. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. J Clin Psychiatry 2010;71:130-7 «PMID: 20122373»PubMed
  28. Brown ES, Carmody TJ, Schmitz JM ym. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res 2009;33:1863-9 «PMID: 19673746»PubMed
  29. Brown ES, Davila D, Nakamura A ym. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence. Alcohol Clin Exp Res 2014;38:2113-8 «PMID: 24976394»PubMed
  30. Brown ES, Garza M, Carmody TJ. A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry 2008;69:701-5 «PMID: 18312058»PubMed
  31. Brown ES, Perantie DC, Dhanani N ym. Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study. J Affect Disord 2006;93:219-22 «PMID: 16519947»PubMed
  32. Brown ES, Sunderajan P, Hu LT ym. A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence. Neuropsychopharmacology 2012;37:2347-54 «PMID: 22669171»PubMed
  33. Burdick KE, Braga RJ, Nnadi CU ym. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction. J Clin Psychiatry 2012;73:103-12 «PMID: 22152405»PubMed
  34. Calabrese JR, Bowden CL, Sachs G ym. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013-24 «PMID: 14628976»PubMed
  35. Calabrese JR, Bowden CL, Sachs GS ym. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999;60:79-88 «PMID: 10084633»PubMed
  36. Calabrese JR, Huffman RF, White RL ym. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008;10:323-33 «PMID: 18271912»PubMed
  37. Calabrese JR, Keck PE Jr, Macfadden W ym. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351-60 «PMID: 15994719»PubMed
  38. Calabrese JR, Keck PE Jr, Starace A ym. Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study. J Clin Psychiatry 2015;76:284-92 «PMID: 25562205»PubMed
  39. Calabrese JR, Pikalov A, Streicher C ym. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder. Eur Neuropsychopharmacol 2017;27:865-876 «PMID: 28689688»PubMed
  40. Calabrese JR, Sanchez R, Jin N ym. Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study. J Clin Psychiatry 2017;78:324-331 «PMID: 28146613»PubMed
  41. Calabrese JR, Shelton MD, Rapport DJ ym. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005;162:2152-61 «PMID: 16263857»PubMed
  42. Calabrese JR, Suppes T, Bowden CL ym. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000;61:841-50 «PMID: 11105737»PubMed
  43. Calabrese JR, Woyshville MJ, Kimmel SE ym. Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 1993;13:280-3 «PMID: 8376616»PubMed
  44. Carlson BX, Ketter TA, Sun W ym. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). Bipolar Disord 2012;14:41-53 «PMID: 22329471»PubMed
  45. Chang K, Saxena K, Howe M. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006;45:298-304 «PMID: 16540814»PubMed
  46. Chapel S, Chiu YY, Hsu J ym. Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis. Clin Ther 2016;38:4-15 «PMID: 26730454»PubMed
  47. Chen R, Zhu X, Capitão LP ym. Psychoeducation for psychiatric inpatients following remission of a manic episode in bipolar I disorder: A randomized controlled trial. Bipolar Disord 2019;21:76-85 «PMID: 29578271»PubMed
  48. Cipriani A, Hawton K, Stockton S ym. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 2013;346:f3646 «PMID: 23814104»PubMed
  49. Cipriani A, Pretty H, Hawton K ym. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005;162:1805-19 «PMID: 16199826»PubMed
  50. Cipriani A, Reid K, Young AH ym. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2013;:CD003196 «PMID: 24132760»PubMed
  51. Cipriani A, Rendell J, Geddes JR. Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis. J Psychopharmacol 2010;24:1729-38 «PMID: 19828571»PubMed
  52. Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev 2006;:CD004362 «PMID: 16856043»PubMed
  53. Citrome L, Ketter TA, Cucchiaro J ym. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed. J Affect Disord 2014;155:20-7 «PMID: 24246116»PubMed
  54. Coles AS, Sasiadek J, George TP. Pharmacotherapies for co-occurring substance use and bipolar disorders: A systematic review. Bipolar Disord 2019;21:595-610 «PMID: 31077521»PubMed
  55. Correll CU, Sheridan EM, DelBello MP. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord 2010;12:116-41 «PMID: 20402706»PubMed
  56. Curtin F, Schulz P. Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. J Affect Disord 2004;78:201-8 «PMID: 15013244»PubMed
  57. Datto C, Pottorf WJ, Feeley L ym. Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depression. Ann Gen Psychiatry 2016;15:9 «PMID: 26973704»PubMed
  58. Davis LL, Bartolucci A, Petty F. Divalproex in the treatment of bipolar depression: a placebo-controlled study. J Affect Disord 2005;85:259-66 «PMID: 15780695»PubMed
  59. DelBello MP, Goldman R, Phillips D ym. Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study. J Am Acad Child Adolesc Psychiatry 2017;56:1015-1025 «PMID: 29173735»PubMed
  60. Delbello MP, Kowatch RA, Adler CM ym. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006;45:305-313 «PMID: 16540815»PubMed
  61. Delbello MP, Schwiers ML, Rosenberg HL ym. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002;41:1216-23 «PMID: 12364843»PubMed
  62. Demant KM, Vinberg M, Kessing LV ym. Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial. PLoS One 2015;10:e0127955 «PMID: 26070195»PubMed
  63. Denicoff KD, Smith-Jackson EE, Bryan AL ym. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder. Am J Psychiatry 1997;154:1456-8 «PMID: 9326833»PubMed
  64. Depp CA, Ceglowski J, Wang VC ym. Augmenting psychoeducation with a mobile intervention for bipolar disorder: a randomized controlled trial. J Affect Disord 2015;174:23-30 «PMID: 25479050»PubMed
  65. Detke HC, DelBello MP, Landry J ym. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2015;54:217-24 «PMID: 25721187»PubMed
  66. Dierckx B, Heijnen WT, van den Broek WW ym. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord 2012;14:146-50 «PMID: 22420590»PubMed
  67. Dolberg OT, Dannon PN, Schreiber S ym. Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study. Bipolar Disord 2002;4 Suppl 1:94-5 «PMID: 12479689»PubMed
  68. Duffy A, Heffer N, Goodday SM ym. Efficacy and tolerability of lithium for the treatment of acute mania in children with bipolar disorder: A systematic review: A report from the ISBD-IGSLi joint task force on lithium treatment. Bipolar Disord 2018;20:583-593 «PMID: 30221434»PubMed
  69. Dunner DL, Stallone F, Fieve RR. Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry 1976;33:117-20 «PMID: 1108832»PubMed
  70. Durgam S, Earley W, Lipschitz A ym. An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression. Am J Psychiatry 2016;173:271-81 «PMID: 26541814»PubMed
  71. Durgam S, Starace A, Li D ym. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. Bipolar Disord 2015;17:63-75 «PMID: 25056368»PubMed
  72. El-Mallakh RS, Marcus R, Baudelet C ym. A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder. J Affect Disord 2012;136:258-66 «PMID: 22209190»PubMed
  73. Fieve RR, Kumbaraci T, Dunner DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 1976;133:925-9 «PMID: 782261»PubMed
  74. Findling RL, Correll CU, Nyilas M ym. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study. Bipolar Disord 2013;15:138-49 «PMID: 23437959»PubMed
  75. Findling RL, Landbloom RL, Szegedi A ym. Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder. J Am Acad Child Adolesc Psychiatry 2015;54:1032-41 «PMID: 26598478»PubMed
  76. Findling RL, McNamara NK, Pavuluri M ym. Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study. J Am Acad Child Adolesc Psychiatry 2019;58:287-296.e4 «PMID: 30738555»PubMed
  77. Findling RL, McNamara NK, Youngstrom EA ym. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005;44:409-17 «PMID: 15843762»PubMed
  78. Findling RL, Nyilas M, Forbes RA ym. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2009;70:1441-51 «PMID: 19906348»PubMed
  79. Findling RL, Robb A, McNamara NK ym. Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study. Pediatrics 2015;136:885-94 «PMID: 26459650»PubMed
  80. Firth J, Teasdale SB, Allott K ym. The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 2019;18:308-324 «PMID: 31496103»PubMed
  81. Fitzgerald PB, Hoy KE, Elliot D ym. A negative double-blind controlled trial of sequential bilateral rTMS in the treatment of bipolar depression. J Affect Disord 2016;198:158-62 «PMID: 27016659»PubMed
  82. Frank E, Kupfer DJ, Thase ME ym. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry 2005;62:996-1004 «PMID: 16143731»PubMed
  83. Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry 2002;63:442-6 «PMID: 12019669»PubMed
  84. Gao K, Ganocy SJ, Conroy C ym. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use. Psychopharmacology (Berl) 2017;234:2233-2244 «PMID: 28536866»PubMed
  85. Geddes JR, Burgess S, Hawton K ym. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004;161:217-22 «PMID: 14754766»PubMed
  86. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 2009;194:4-9 «PMID: 19118318»PubMed
  87. Geller B, Cooper TB, Sun K ym. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998;37:171-8 «PMID: 9473913»PubMed
  88. Ghaemi SN, Gilmer WS, Goldberg JF ym. Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study. J Clin Psychiatry 2007;68:1840-4 «PMID: 18162014»PubMed
  89. Ghaemi SN, Ostacher MM, El-Mallakh RS ym. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry 2010;71:372-80 «PMID: 20409444»PubMed
  90. Ghaemi SN, Wingo AP, Filkowski MA ym. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand 2008;118:347-56 «PMID: 18727689»PubMed
  91. Gijsman HJ, Geddes JR, Rendell JM ym. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004;161:1537-47 «PMID: 15337640»PubMed
  92. Gliddon E, Cosgrove V, Berk L ym. A randomized controlled trial of MoodSwings 2.0: An internet-based self-management program for bipolar disorder. Bipolar Disord 2019;21:28-39 «PMID: 29931798»PubMed
  93. Goldberg JF, Burdick KE, Endick CJ. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 2004;161:564-6 «PMID: 14992985»PubMed
  94. Goldberg JF, Perlis RH, Ghaemi SN ym. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry 2007;164:1348-55 «PMID: 17728419»PubMed
  95. Goldstein TR, Fersch-Podrat RK, Rivera M ym. Dialectical behavior therapy for adolescents with bipolar disorder: results from a pilot randomized trial. J Child Adolesc Psychopharmacol 2015;25:140-9 «PMID: 25010702»PubMed
  96. Goodwin GM, Bowden CL, Calabrese JR ym. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004;65:432-41 «PMID: 15096085»PubMed
  97. Gregory VL Jr. Cognitive-behavioral therapy for depression in bipolar disorder: a meta-analysis. J Evid Based Soc Work 2010;7:269-79 «PMID: 20799127»PubMed
  98. Greil W, Kleindienst N. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol 1999;14:283-5 «PMID: 10529071»PubMed
  99. Hadjipavlou G, Mok H, Yatham LN. Bipolar II disorder: an overview of recent developments. Can J Psychiatry 2004;49:802-12 «PMID: 15679203»PubMed
  100. Hadjipavlou G, Mok H, Yatham LN. Pharmacotherapy of bipolar II disorder: a critical review of current evidence. Bipolar Disord 2004;6:14-25 «PMID: 14996137»PubMed
  101. Hartong EG, Moleman P, Hoogduin CA ym. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 2003;64:144-51 «PMID: 12633122»PubMed
  102. Harvey AG, Soehner AM, Kaplan KA ym. Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial. J Consult Clin Psychol 2015;83:564-77 «PMID: 25622197»PubMed
  103. Hirschfeld RM, Baker JD, Wozniak P ym. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. J Clin Psychiatry 2003;64:841-6 «PMID: 12934987»PubMed
  104. Hirschfeld RM, Holzer C, Calabrese JR ym. Validity of the mood disorder questionnaire: a general population study. Am J Psychiatry 2003;160:178-80 «PMID: 12505821»PubMed
  105. Hirschfeld RM, Kasper S. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. Int J Neuropsychopharmacol 2004;7:507-22 «PMID: 15458610»PubMed
  106. Hu SH, Lai JB, Xu DR ym. Efficacy of repetitive transcranial magnetic stimulation with quetiapine in treating bipolar II depression: a randomized, double-blinded, control study. Sci Rep 2016;6:30537 «PMID: 27460201»PubMed
  107. Icro Maremmani AG, Bacciardi S, Rovai L ym. Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study. Int J Environ Res Public Health 2014;11:12983-96 «PMID: 25514151»PubMed
  108. Inder ML, Crowe MT, Luty SE ym. Randomized, controlled trial of Interpersonal and Social Rhythm Therapy for young people with bipolar disorder. Bipolar Disord 2015;17:128-38 «PMID: 25346391»PubMed
  109. Inder ML, Crowe MT, Moor S ym. Three-year follow-up after psychotherapy for young people with bipolar disorder. Bipolar Disord 2017;: «PMID: 29271072»PubMed
  110. Jacobsen FM. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry 1993;54:229-34 «PMID: 8331092»PubMed
  111. Jones SH, Smith G, Mulligan LD ym. Recovery-focused cognitive-behavioural therapy for recent-onset bipolar disorder: randomised controlled pilot trial. Br J Psychiatry 2015;206:58-66 «PMID: 25213157»PubMed
  112. Kane JM, Quitkin FM, Rifkin A ym. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 1982;39:1065-9 «PMID: 6810839»PubMed
  113. Keck PE Jr, Calabrese JR, McIntyre RS ym. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 2007;68:1480-91 «PMID: 17960961»PubMed
  114. Keck PE Jr, Calabrese JR, McQuade RD ym. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 2006;67:626-37 «PMID: 16669728»PubMed
  115. Keck PE Jr, Marcus R, Tourkodimitris S ym. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003;160:1651-8 «PMID: 12944341»PubMed
  116. Keck PE Jr, McElroy SL, Tugrul KC ym. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:305-8 «PMID: 8253698»PubMed
  117. Keck PE Jr, Versiani M, Potkin S ym. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003;160:741-8 «PMID: 12668364»PubMed
  118. Kemp DE, Gao K, Ganocy SJ ym. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. J Clin Psychiatry 2009;70:113-21 «PMID: 19192457»PubMed
  119. Kessing LV, Hansen HV, Hvenegaard A ym. Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial. Br J Psychiatry 2013;202:212-9 «PMID: 23349295»PubMed
  120. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000;42 Suppl 1:2-10 «PMID: 11093063»PubMed
  121. Lam DH, Bright J, Jones S, Hayward P ym. Cognitive Therapy for Bipolar Illness – A pilot Study of Relapse prevention. Cognitive Ther Res 2000;24:503-20
  122. Lam DH, Hayward P, Watkins ER ym. Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years. Am J Psychiatry 2005;162:324-9 «PMID: 15677598»PubMed
  123. Lam DH, Watkins ER, Hayward P ym. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003;60:145-52 «PMID: 12578431»PubMed
  124. Lauder S, Chester A, Castle D ym. A randomized head to head trial of MoodSwings.net.au: an Internet based self-help program for bipolar disorder. J Affect Disord 2015;171:13-21 «PMID: 25282145»PubMed
  125. Lewandowski KE, Sperry SH, Cohen BM ym. Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): Efficacy of a Randomized Controlled Trial of Cognitive Remediation Versus Active Control. J Clin Psychiatry 2017;78:e1242-e1249 «PMID: 29045770»PubMed
  126. Leverich GS, Altshuler LL, Frye MA ym. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006;163:232-9 «PMID: 16449476»PubMed
  127. Li H, Gu N, Zhang H ym. Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 2016;233:1289-97 «PMID: 26911380»PubMed
  128. Liu HY, Potter MP, Woodworth KY ym. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2011;50:749-62.e39 «PMID: 21784295»PubMed
  129. Loebel A, Cucchiaro J, Silva R ym. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry 2014;171:169-77 «PMID: 24170221»PubMed
  130. Loebel A, Cucchiaro J, Silva R ym. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry 2014;171:160-8 «PMID: 24170180»PubMed
  131. Lovas DA, Schuman-Olivier Z. Mindfulness-based cognitive therapy for bipolar disorder: A systematic review. J Affect Disord 2018;240:247-261 «PMID: 30086469»PubMed
  132. Macfadden W, Alphs L, Haskins JT ym. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. Bipolar Disord 2009;11:827-39 «PMID: 19922552»PubMed
  133. Macneil CA, Hasty M, Cotton S ym. Can a targeted psychological intervention be effective for young people following a first manic episode? Results from an 18-month pilot study. Early Interv Psychiatry 2012;6:380-8 «PMID: 22225628»PubMed
  134. Mantere O, Suominen K, Leppämäki S ym. The clinical characteristics of DSM-IV bipolar I and II disorders: baseline findings from the Jorvi Bipolar Study (JoBS). Bipolar Disord 2004;6:395-405 «PMID: 15383132»PubMed
  135. Marcus R, Khan A, Rollin L ym. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar Disord 2011;13:133-44 «PMID: 21443567»PubMed
  136. Martinotti G, Andreoli S, Di Nicola M ym. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Hum Psychopharmacol 2008;23:417-24 «PMID: 18425995»PubMed
  137. McCloud TL, Caddy C, Jochim J ym. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. Cochrane Database Syst Rev 2015;:CD011611 «PMID: 26415966»PubMed
  138. McElroy SL, Weisler RH, Chang W ym. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 2010;71:163-74 «PMID: 20122366»PubMed
  139. McGirr A, Vöhringer PA, Ghaemi SN ym. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry 2016;3:1138-1146 «PMID: 28100425»PubMed
  140. McIntyre RS, Brecher M, Paulsson B ym. Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 2005;15:573-85 «PMID: 16139175»PubMed
  141. McIntyre RS, Cohen M, Zhao J ym. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. Bipolar Disord 2009;11:673-86 «PMID: 19839993»PubMed
  142. McIntyre RS, Cohen M, Zhao J ym. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study. J Affect Disord 2010;126:358-65 «PMID: 20537396»PubMed
  143. McIntyre RS, Cohen M, Zhao J ym. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial. J Affect Disord 2010;122:27-38 «PMID: 20096936»PubMed
  144. McIntyre RS. Aripiprazole for the maintenance treatment of bipolar I disorder: A review. Clin Ther 2010;32 Suppl 1:S32-8 «PMID: 20152551»PubMed
  145. Meyer TD, Hautzinger M. Cognitive behaviour therapy and supportive therapy for bipolar disorders: relapse rates for treatment period and 2-year follow-up. Psychol Med 2012;42:1429-39 «PMID: 22099722»PubMed
  146. Miklowitz DJ, Axelson DA, Birmaher B ym. Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Arch Gen Psychiatry 2008;65:1053-61 «PMID: 18762591»PubMed
  147. Miklowitz DJ, George EL, Richards JA ym. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry 2003;60:904-12 «PMID: 12963672»PubMed
  148. Miklowitz DJ, Otto MW, Frank E ym. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry 2007;64:419-26 «PMID: 17404119»PubMed
  149. Miklowitz DJ, Schneck CD, George EL ym. Pharmacotherapy and family-focused treatment for adolescents with bipolar I and II disorders: a 2-year randomized trial. Am J Psychiatry 2014;171:658-67 «PMID: 24626789»PubMed
  150. Miura T, Noma H, Furukawa TA ym. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry 2014;1:351-9 «PMID: 26360999»PubMed
  151. Murasaki M, Koyama T, Kanba S ym. Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression. Psychopharmacology (Berl) 2018;235:2859-2869 «PMID: 30069587»PubMed
  152. Muzina DJ, Gao K, Kemp DE ym. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 2011;72:813-9 «PMID: 20816041»PubMed
  153. Nahas Z, Kozel FA, Li X ym. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord 2003;5:40-7 «PMID: 12656937»PubMed
  154. Nejtek VA, Avila M, Chen LA ym. Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. J Clin Psychiatry 2008;69:1257-66 «PMID: 18681757»PubMed
  155. Nemeroff CB, Evans DL, Gyulai L ym. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158:906-12 «PMID: 11384898»PubMed
  156. NICE. Bipolar Disorder. The assessment and management of bipolar disorder in adults, and young people in primary and secondary care. Updated edition. National Clinical Guideline Number 185, 2014. https://www.nice.org.uk/guidance/cg185/evidence/full-guideline-pdf-4840895629
  157. O'Donnell LA, Axelson DA, Kowatch RA ym. Enhancing quality of life among adolescents with bipolar disorder: A randomized trial of two psychosocial interventions. J Affect Disord 2017;219:201-208 «PMID: 28570966»PubMed
  158. Ostacher M, Ng-Mak D, Patel P ym. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis. World J Biol Psychiatry 2018;19:586-601 «PMID: 28264635»PubMed
  159. Patel NC, Delbello MP, Bryan HS ym. Open-label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006;45:289-297 «PMID: 16540813»PubMed
  160. Pavuluri MN, Henry DB, Carbray JA ym. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial. Bipolar Disord 2005;7:266-73 «PMID: 15898964»PubMed
  161. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994;164:549-50 «PMID: 8038948»PubMed
  162. Petrakis IL, Nich C, Ralevski E. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophr Bull 2006;32:644-54 «PMID: 16887890»PubMed
  163. Poolsup N, Li Wan Po A, de Oliveira IR. Systematic overview of lithium treatment in acute mania. J Clin Pharm Ther 2000;25:139-56 «PMID: 10849192»PubMed
  164. Pope HG Jr, McElroy SL, Keck PE Jr ym. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 1991;48:62-8 «PMID: 1984763»PubMed
  165. Popiolek K, Bejerot S, Brus O ym. Electroconvulsive therapy in bipolar depression - effectiveness and prognostic factors. Acta Psychiatr Scand 2019;140:196-204 «PMID: 31334829»PubMed
  166. Post RM, Altshuler LL, Leverich GS ym. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006;189:124-31 «PMID: 16880481»PubMed
  167. Potkin SG, Keck PE Jr, Segal S ym. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 2005;25:301-10 «PMID: 16012271»PubMed
  168. Prisciandaro JJ, Brown DG, Brady KT ym. Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. Psychiatry Res 2011;188:361-5 «PMID: 21641663»PubMed
  169. Quiroz JA, Yatham LN, Palumbo JM ym. Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder. Biol Psychiatry 2010;68:156-62 «PMID: 20227682»PubMed
  170. Rea MM, Tompson MC, Miklowitz DJ ym. Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. J Consult Clin Psychol 2003;71:482-92 «PMID: 12795572»PubMed
  171. Rendell JM, Gijsman HJ, Bauer MS ym. Risperidone alone or in combination for acute mania. Cochrane Database Syst Rev 2006;:CD004043 «PMID: 16437472»PubMed
  172. Rendell JM, Gijsman HJ, Keck P ym. Olanzapine alone or in combination for acute mania. Cochrane Database Syst Rev 2003;:CD004040 «PMID: 12918000»PubMed
  173. Sachs G, Chengappa KN, Suppes T ym. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2004;6:213-23 «PMID: 15117400»PubMed
  174. Sachs GS, Greenberg WM, Starace A ym. Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial. J Affect Disord 2015;174:296-302 «PMID: 25532076»PubMed
  175. Sachs GS, Nierenberg AA, Calabrese JR ym. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007;356:1711-22 «PMID: 17392295»PubMed
  176. Sajatovic M, Forester BP, Tsai J ym. Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies. J Clin Psychiatry 2016;77:e1324-e1331 «PMID: 27529375»PubMed
  177. Sajatovic M, Gyulai L, Calabrese JR ym. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry 2005;13:305-11 «PMID: 15845756»PubMed
  178. Sajatovic M, Madhusoodanan S, Coconcea N. Managing bipolar disorder in the elderly: defining the role of the newer agents. Drugs Aging 2005;22:39-54 «PMID: 15663348»PubMed
  179. Salloum IM, Cornelius JR, Daley DC ym. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005;62:37-45 «PMID: 15630071»PubMed
  180. Sanchez-Moreno J, Bonnín C, González-Pinto A ym. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study. Eur Neuropsychopharmacol 2017;27:350-359 «PMID: 28126401»PubMed
  181. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry 2012;73:81-6 «PMID: 21903025»PubMed
  182. Schaffer CB, Garvey MJ. Use of lithium in acutely manic elderly patients. Clin Gerontol 1984;3:58-60
  183. Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry 2007;64:442-55 «PMID: 17404121»PubMed
  184. Schoeyen HK, Kessler U, Andreassen OA ym. Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment. Am J Psychiatry 2015;172:41-51 «PMID: 25219389»PubMed
  185. Scott J, Garland A, Moorhead S. A pilot study of cognitive therapy in bipolar disorders. Psychol Med 2001;31:459-67 «PMID: 11305854»PubMed
  186. Scott J, Paykel E, Morriss R ym. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 2006;188:313-20 «PMID: 16582056»PubMed
  187. Severus E, Taylor MJ, Sauer C ym. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord 2014;2:15 «PMID: 25530932»PubMed
  188. Silva MT, Zimmermann IR, Galvao TF ym. Olanzapine plus fluoxetine for bipolar disorder: a systematic review and meta-analysis. J Affect Disord 2013;146:310-8 «PMID: 23218251»PubMed
  189. Singh JB, Zarate CA Jr. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials. Bipolar Disord 2006;8:696-709 «PMID: 17156156»PubMed
  190. Sit DK, McGowan J, Wiltrout C ym. Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry 2018;175:131-139 «PMID: 28969438»PubMed
  191. Smith KA, Cipriani A. Lithium and suicide in mood disorders: Updated meta-review of the scientific literature. Bipolar Disord 2017;19:575-586 «PMID: 28895269»PubMed
  192. Smith LA, Cornelius V, Warnock A ym. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. Bipolar Disord 2007;9:551-60 «PMID: 17845269»PubMed
  193. Solé B, Bonnin CM, Mayoral M ym. Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms. Eur Neuropsychopharmacol 2015;25:257-64 «PMID: 24906790»PubMed
  194. Solomon DA, Ryan CE, Keitner GI ym. A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J Clin Psychiatry 1997;58:95-9 «PMID: 9108809»PubMed
  195. Soo SA, Zhang ZW, Khong SJ ym. Randomized Controlled Trials of Psychoeducation Modalities in the Management of Bipolar Disorder: A Systematic Review. J Clin Psychiatry 2018;79: «PMID: 29727072»PubMed
  196. Stedman M, Pettinati HM, Brown ES ym. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcohol Clin Exp Res 2010;34:1822-31 «PMID: 20626727»PubMed
  197. Stokes PE, Shamoian CA, Stoll PM ym. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971;1:1319-25 «PMID: 4103395»PubMed
  198. Suppes T, Brown E, Schuh LM ym. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data. J Affect Disord 2005;89:69-77 «PMID: 16253344»PubMed
  199. Suppes T, Datto C, Minkwitz M ym. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. J Affect Disord 2010;121:106-15 «PMID: 19903574»PubMed
  200. Suppes T, Datto C, Minkwitz M ym. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. J Affect Disord 2014;168:485-93 «PMID: 25538990»PubMed
  201. Suppes T, Kroger H, Pikalov A ym. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts. J Psychiatr Res 2016;78:86-93 «PMID: 27089521»PubMed
  202. Suppes T, Vieta E, Gustafsson U ym. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials. Depress Anxiety 2013;30:1089-98 «PMID: 23761037»PubMed
  203. Suppes T, Vieta E, Liu S ym. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry 2009;166:476-88 «PMID: 19289454»PubMed
  204. Suttajit S, Srisurapanont M, Maneeton N ym. Quetiapine for acute bipolar depression: a systematic review and meta-analysis. Drug Des Devel Ther 2014;8:827-38 «PMID: 25028535»PubMed
  205. Swartz HA, Rucci P, Thase ME ym. Psychotherapy Alone and Combined With Medication as Treatments for Bipolar II Depression: A Randomized Controlled Trial. J Clin Psychiatry 2018;79: «PMID: 28703949»PubMed
  206. Szegedi A, Durgam S, Mackle M ym. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder. Am J Psychiatry 2018;175:71-79 «PMID: 28946761»PubMed
  207. Szmulewicz AG, Angriman F, Samamé C ym. Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis. Acta Psychiatr Scand 2017;135:527-538 «PMID: 28256707»PubMed
  208. Tavares DF, Myczkowski ML, Alberto RL ym. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial. Neuropsychopharmacology 2017;42:2593-2601 «PMID: 28145409»PubMed
  209. Thase ME, Macfadden W, Weisler RH ym. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006;26:600-9 «PMID: 17110817»PubMed
  210. Tohen M, Calabrese JR, Sachs GS ym. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006;163:247-56 «PMID: 16449478»PubMed
  211. Tohen M, Chengappa KN, Suppes T ym. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry 2004;184:337-45 «PMID: 15056579»PubMed
  212. Tohen M, Greil W, Calabrese JR ym. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005;162:1281-90 «PMID: 15994710»PubMed
  213. Tohen M, Katagiri H, Fujikoshi S ym. Efficacy of olanzapine monotherapy in acute bipolar depression: a pooled analysis of controlled studies. J Affect Disord 2013;149:196-201 «PMID: 23485111»PubMed
  214. Tohen M, Ketter TA, Zarate CA ym. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003;160:1263-71 «PMID: 12832240»PubMed
  215. Tohen M, McDonnell DP, Case M ym. Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression. Br J Psychiatry 2012;201:376-82 «PMID: 22918966»PubMed
  216. Tohen M, Vieta E, Calabrese J ym. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-88 «PMID: 14609883»PubMed
  217. Tolliver BK, Desantis SM, Brown DG ym. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord 2012;14:54-63 «PMID: 22329472»PubMed
  218. Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand 2003;108:4-14 «PMID: 12807371»PubMed
  219. Torrent C, Bonnin Cdel M, Martínez-Arán A ym. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry 2013;170:852-9 «PMID: 23511717»PubMed
  220. Tsai AC, Rosenlicht NZ, Jureidini JN ym. Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature. PLoS Med 2011;8:e1000434 «PMID: 21559324»PubMed
  221. Tseng PT, Chen YW, Tu KY ym. Light therapy in the treatment of patients with bipolar depression: A meta-analytic study. Eur Neuropsychopharmacol 2016;26:1037-47 «PMID: 26993616»PubMed
  222. van der Loos ML, Mulder P, Hartong EG ym. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. Bipolar Disord 2011;13:111-7 «PMID: 21320258»PubMed
  223. Wang HR, Woo YS, Ahn HS ym. THE VALIDITY OF THE MOOD DISORDER QUESTIONNAIRE FOR SCREENING BIPOLAR DISORDER: A META-ANALYSIS. Depress Anxiety 2015;32:527-38 «PMID: 26010478»PubMed
  224. Wang M, Tong JH, Huang DS ym. Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study. Psychopharmacology (Berl) 2014;231:2811-8 «PMID: 24481570»PubMed
  225. Wang YY, Xu DD, Liu R ym. Comparison of the screening ability between the 32-item Hypomania Checklist (HCL-32) and the Mood Disorder Questionnaire (MDQ) for bipolar disorder: A meta-analysis and systematic review. Psychiatry Res 2019;273:461-466 «PMID: 30684793»PubMed
  226. Vázquez GH, Tondo L, Undurraga J ym. Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol 2013;16:1673-85 «PMID: 23428003»PubMed
  227. Weisler RH, Hirschfeld R, Cutler AJ ym. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. CNS Drugs 2006;20:219-31 «PMID: 16529527»PubMed
  228. Weisler RH, Nolen WA, Neijber A ym. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). J Clin Psychiatry 2011;72:1452-64 «PMID: 22054050»PubMed
  229. Weiss RD, Griffin ML, Jaffee WB ym. A "community-friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Depend 2009;104:212-9 «PMID: 19573999»PubMed
  230. Weiss RD, Griffin ML, Kolodziej ME ym. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry 2007;164:100-7 «PMID: 17202550»PubMed
  231. Vieta E, Bourin M, Sanchez R ym. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. Br J Psychiatry 2005;187:235-42 «PMID: 16135860»PubMed
  232. Vieta E, Gastó C, Colom F ym. Role of risperidone in bipolar II: an open 6-month study. J Affect Disord 2001;67:213-9 «PMID: 11869771»PubMed
  233. Vieta E, Suppes T, Eggens I ym. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 2008;109:251-63 «PMID: 18579216»PubMed
  234. Vieta E, Torrent C, Martinez-Aran A. Functional Remediation for Bipolar Disorder. Cambridge University Press, Cambridge, UK 2014
  235. Xuan R, Li X, Qiao Y ym. Mindfulness-based cognitive therapy for bipolar disorder: A systematic review and meta-analysis. Psychiatry Res 2020;290:113116 «PMID: 32480120»PubMed
  236. Yorguner Kupeli N, Bulut NS, Carkaxhiu Bulut G ym. Efficacy of bright light therapy in bipolar depression. Psychiatry Res 2018;260:432-438 «PMID: 29268206»PubMed
  237. Young AH, Calabrese JR, Gustafsson U ym. Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. Int J Bipolar Disord 2013;1:10 «PMID: 25505677»PubMed
  238. Young AH, McElroy SL, Bauer M ym. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 2010;71:150-62 «PMID: 20122369»PubMed
  239. Young AH, McElroy SL, Olausson B ym. A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder. World J Biol Psychiatry 2014;15:96-112 «PMID: 22404704»PubMed
  240. Young RC, Gyulai L, Mulsant BH ym. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry 2004;12:342-57 «PMID: 15249272»PubMed
  241. Youngstrom EA, Egerton GA, Genzlinger J ym. Improving the global identification of bipolar spectrum disorders: Meta-analysis of the diagnostic accuracy of checklists. Psychol Bull 2018;144:315-342 «PMID: 29389179»PubMed
  242. Zarate CA Jr, Payne JL, Singh J ym. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 2004;56:54-60 «PMID: 15219473»PubMed
  243. Zaretsky A, Lancee W, Miller C ym. Is cognitive-behavioural therapy more effective than psychoeducation in bipolar disorder? Can J Psychiatry 2008;53:441-8 «PMID: 18674402»PubMed
  244. Zhou TH, Dang WM, Ma YT ym. Clinical efficacy, onset time and safety of bright light therapy in acute bipolar depression as an adjunctive therapy: A randomized controlled trial. J Affect Disord 2018;227:90-96 «PMID: 29053981»PubMed
  245. Zimmerman M, Galione JN. Screening for bipolar disorder with the Mood Disorders Questionnaire: a review. Harv Rev Psychiatry 2011;19:219-28 «PMID: 21916824»PubMed
  246. Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397-408 «PMID: 8120153»PubMed
Artikkelin tunnus: nix02925 (050.076)
© Suomalainen Lääkäriseura Duodecim

Käypä hoito -suositus

Anna palautetta
Linkkien värikoodit